Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chronic cerebrospinal venous insufficiency and multiple sclerosis: history and background.
Dementia in multiple sclerosis: Report of a case with cortical gray matter involvement and frontotemporal-like clinical features.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.
Cell-based therapy approaches: the hope for incurable diseases.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
[Clinical significance of T-regulatory cells in multiple sclerosis.]
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.
[How to use Japanese guidelines for the treatment of multiple sclerosis].
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Memory impairment in multiple sclerosis is due to a core deficit in initial learning.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »